Gut microbiome alterations predictive of cancer risk
In the authors' words
Cancer is the second leading cause of death worldwide. A large proportion of cancer deaths is associated with modifiable risk factors, such as tobacco use and dietary factors. This highlights the critical role of prevention to reduce cancer deaths, which relies on both identifying individuals at risk and mitigating that risk. Here, we focus on risk stratification by leveraging gut microbiome alterations. Utilizing two cancer discovery cohorts and four general population cohorts across different European countries - encompassing 16,255 individuals, including 3,341 cancer cases - we first establish the existence of common gut microbiome alterations across multiple distinct malignancies (lung, kidney, and breast). We demonstrate that these alterations are conserved in populations from France, Finland, the Netherlands, and Latvia. Crucially, we show that individuals who develop cancer after microbiome sampling (n = 1,642) harbor microbiome alterations similar to those found in clinically diagnosed cancer cases, albeit to a lesser degree. This indicates that the gut microbiome evolves towards a cancer-associated state well before clinical diagnosis. Finally, we demonstrate that the extent of microbiome alterations can effectively stratify both the patients with diagnosed cancer and individuals at elevated cancer risk.
Appeared: Thursday, September 24. medRxiv. Preprint, not yet peer-reviewed.